Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037713
Filing Date
2020-08-06
Accepted
2020-08-06 16:04:00
Documents
50
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 Q2 2020 10-Q gern-10q_20200630.htm   iXBRL 10-Q 2466970
2 EX-31.1 gern-ex311_6.htm EX-31.1 17405
3 EX-31.2 gern-ex312_7.htm EX-31.2 17419
4 EX-32.1 gern-ex321_9.htm EX-32.1 7632
5 EX-32.2 gern-ex322_8.htm EX-32.2 7614
  Complete submission text file 0001564590-20-037713.txt   7742537

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gern-20200630.xsd EX-101.SCH 34928
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gern-20200630_cal.xml EX-101.CAL 45316
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gern-20200630_def.xml EX-101.DEF 115516
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20200630_lab.xml EX-101.LAB 299743
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20200630_pre.xml EX-101.PRE 215813
11 EXTRACTED XBRL INSTANCE DOCUMENT gern-10q_20200630_htm.xml XML 1636364
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 201081513
SIC: 2834 Pharmaceutical Preparations